According to SAMHSA’s 2023 National Survey on Drug Use and Health, only about 10% of the 48.7 million Americans who needed substance use treatment in the prior year actually received it at a specialty facility. For people in the Indianapolis area searching for drug rehab, the bottleneck usually isn’t motivation. It’s knowing how to compare options without getting misled by marketing that sounds identical from one facility to the next. This guide gives you a concrete framework for doing exactly that.
Why where you receive treatment matters more than most people realize
SAMHSA’s 2020 Treatment Episode Data Set, which tracked more than 1.5 million admissions across the country, found that program quality and the clinical environment are stronger predictors of sustained recovery than the specific substance involved. The facility you choose is not a background detail. It is one of the most consequential decisions in this process.
That stakes-setting matters for one practical reason: a poor placement is recoverable, but it costs time that addiction doesn’t pause to give back. Every week spent in a program that isn’t clinically appropriate delays real treatment. The framework in this guide walks through accreditation, staff quality, evidence-based modalities, dual diagnosis capacity, and aftercare structure, and then shows you how to apply all of it when evaluating specific Indianapolis-area facilities.
What “drug rehab” actually covers: understanding the levels of care
Most people searching for drug rehab in Indianapolis, Indiana use the term as if it describes one thing. It describes at least five distinct levels of care, each appropriate for a different severity of need. The American Society of Addiction Medicine (ASAM) publishes placement criteria, updated most recently in the ASAM Criteria fourth edition, that guide clinicians in matching patients to the correct level. Before calling any facility, knowing which level you or your family member actually needs will save you from placements that are either dangerously under-resourced or unnecessarily restrictive.
Detox vs. treatment: a distinction that changes everything
Medical detox and rehabilitation are not the same thing, and confusing them is one of the most common and costly mistakes families make. Detox manages the physiological withdrawal process, which for alcohol, benzodiazepines, and opioids can be medically dangerous. It does not address the psychological, behavioral, or social drivers of addiction.
A 2019 study published in the journal Drug and Alcohol Dependence, analyzing outcomes across 1,200 opioid-dependent patients, found that individuals who completed detox but did not transition to structured treatment relapsed at a rate exceeding 80% within 30 days. The mechanism is straightforward: removing a substance from the body without changing the environment and behaviors that supported its use leaves the underlying condition entirely untreated. Detox is the beginning of treatment, not a substitute for it.
Residential vs. outpatient: matching intensity to need
Residential treatment (also called inpatient) places you in a structured, 24-hour clinical environment. Partial hospitalization programs (PHP) offer intensive daytime treatment, typically five to six hours per day, without overnight stays. Intensive outpatient programs (IOP) run three to four hours per day, several days per week. Standard outpatient provides weekly or biweekly sessions.
A 2020 NIDA review of placement research found that co-occurring mental health conditions, an unstable home environment, and prior treatment failure are the three factors that most reliably indicate the need for residential-level care. If any of those three apply, outpatient treatment as a starting point is the wrong match. The concrete action here is simple: before calling any Indianapolis-area facility, ask directly which ASAM criteria they use to determine placement level, and ask where you or your family member falls on that scale.
The five factors that actually separate good facilities from poor ones
A 2021 NIDA analysis of long-term recovery predictors identified five facility-level factors that consistently correlate with better outcomes at the 12-month and 36-month mark: accreditation status, clinician credentials and caseload, use of evidence-based modalities, integrated dual diagnosis treatment, and structured continuing care. These are the criteria worth evaluating. Every other factor, including amenities, private rooms, and proximity to nature, is secondary.
Accreditation and licensing: the baseline you cannot skip
Two accrediting bodies matter in this space: The Joint Commission and CARF (Commission on Accreditation of Rehabilitation Facilities). Both conduct independent audits of clinical practice, staff qualifications, patient rights protections, and safety standards. Neither accreditation guarantees a great experience, but the absence of either is a concrete red flag.
A 2018 report from the HHS Office of Inspector General found that accreditation status was the single strongest proxy for regulatory compliance among substance use treatment facilities reviewed in the study. Unaccredited facilities are disproportionately represented in state enforcement actions. The action: look up any Indianapolis-area facility on the SAMHSA treatment locator at findtreatment.gov and verify its license status before scheduling a tour.
Staff credentials and the therapist-to-client ratio
A 2017 study published in Psychiatric Services, examining 185 outpatient substance use programs, found that facilities with a counselor-to-client ratio above 1:20 produced significantly worse outcomes at 6 months compared to facilities maintaining ratios at or below 1:12. High caseloads mean less individualized attention, shorter session durations, and less time to address co-occurring conditions.
When you call a facility, ask two questions directly: “What is your current therapist-to-client ratio?” and “What credentials do your primary clinicians hold?” Look for licensed professional counselors (LPC), licensed clinical social workers (LCSW), or licensed alcohol and drug counselors (LADC) as the baseline. A program staffed primarily by peer recovery coaches without licensed clinicians is not equipped to treat complex addiction.
Evidence-based treatment modalities: what the research actually supports
Three modalities carry the strongest outcome evidence. Cognitive Behavioral Therapy (CBT) has the deepest evidence base for substance use disorders, with a 2017 Cochrane Review of 53 randomized controlled trials confirming its efficacy across alcohol, opioid, and stimulant use disorders. Medication-Assisted Treatment (MAT) using buprenorphine, methadone, or naltrexone for opioid use disorder reduces mortality by up to 50%, according to a 2019 NIH systematic review of 19 studies covering 17,000 patients. Dialectical Behavior Therapy (DBT) has particular value for clients with co-occurring borderline personality disorder or trauma histories.
What this means in practice: ask any facility to name the evidence-based modalities in their program before committing. A facility that relies primarily on 12-step attendance and group meetings without structured clinical therapy is not delivering evidence-based treatment. 12-step participation has value as a community support structure, but it is not a substitute for clinical care.
Dual diagnosis capability: the factor most people miss
SAMHSA’s 2022 National Survey on Drug Use and Health found that among adults with a substance use disorder, 49.7% also had a co-occurring mental health condition. Nearly half. Facilities that treat addiction in isolation, without the infrastructure to address depression, anxiety, PTSD, or other psychiatric conditions, are failing a large portion of the people in their care.
True dual diagnosis treatment means psychiatrists and addiction counselors share treatment plans and meet regularly about the same patient. Sequential treatment, where addiction is addressed first and mental health is treated afterward in a separate program, produces worse outcomes because neither condition is stable when the other is active. Ask any facility directly: “Do your psychiatrists and addiction counselors share treatment plans and meet together about my case?” If the answer is vague, the program is probably not integrated.
Aftercare planning and continuing care: where outcomes are actually decided
A 2014 longitudinal study in the Journal of Substance Abuse Treatment, tracking 1,326 patients across five years, found that participation in continuing care reduced relapse rates by 37% compared to patients who completed residential treatment without structured follow-up. More notably, the benefit compounded over time: patients with 12 months of continuing care showed better outcomes at five years than those with only 6 months. The first 90 days after discharge are the highest-risk period, and continuing care is the primary protective factor.
A quality facility starts discharge planning on day one, not in the final week of treatment. Red flag: any program that hands you a resource pamphlet at checkout and calls it aftercare planning. Look for a specific continuing care plan that includes step-down level of care, medication management if applicable, sober living referrals if needed, and scheduled outpatient therapy appointments before discharge.
How to evaluate indianapolis-area facilities against these standards
SAMHSA’s 2022 National Survey on Drug Use and Health reported that Indiana’s rate of illicit drug use disorder among adults aged 18 and older was 3.5%, slightly above the national average of 3.2%, with opioids and methamphetamine driving the majority of treatment admissions. Understanding the local landscape matters because it shapes what good facilities in the Indianapolis market are built to treat.
Evaluating options follows a sequence: online research first, verification second, direct contact third, and an in-person tour as close to the decision point as possible.
Questions to ask during the first phone call
The first phone call is a screening, not an enrollment conversation. A 2016 study in the Journal of Substance Abuse Treatment found that families who asked structured questions during initial facility contact were significantly better matched to appropriate care levels than those who relied on facility-led intake conversations.
Cover these areas in sequence. Ask about accreditation status and which body granted it. Ask what levels of care the facility offers and what placement criteria they use. Ask whether they have integrated dual diagnosis treatment with shared care planning. Ask whether they accept PPO or private insurance and whether they verify benefits before admission. Ask what continuing care looks like and when discharge planning begins. Five questions, asked on the first call, will eliminate most poor matches before you invest time in a tour.
What a facility tour should tell you
A 2019 report from the National Center on Addiction and Substance Abuse found that physical environment and staff interaction style were significant predictors of patient engagement during treatment. What to watch for on a tour: Do staff interact with patients during common times, or are patients largely left unsupervised? Is the program schedule posted and structured? Is the clinical space separate from residential space, indicating organized programming rather than informal group time?
If a facility won’t allow you to tour before admission, treat that as a serious red flag. Transparency about the clinical environment is a baseline expectation, not a privilege.
The insurance question: understanding what your PPO actually covers
A 2023 Kaiser Family Foundation analysis of private insurance claims found that people with PPO coverage received on average 6.7 more days of inpatient substance use treatment per admission than those with HMO plans, due to broader out-of-network access and less restrictive pre-authorization requirements. PPO coverage is genuinely more flexible for addiction treatment, but understanding how to use it correctly changes what you can access.
The Mental Health Parity and Addiction Equity Act (MHPAEA), federal law enacted in 2008 and strengthened in 2024 rulemaking, requires that insurance plans cover substance use disorder treatment at parity with medical and surgical benefits. This means your insurer cannot impose stricter prior authorization requirements or lower day limits on addiction treatment than they apply to comparable medical care. If a plan denies coverage or limits days in ways that wouldn’t apply to a comparable medical condition, that is a parity violation you can appeal.
The concrete action: call the member services number on your insurance card before choosing a facility. Ask three things: whether the facility is in-network or what your out-of-network benefits cover, what the pre-authorization process requires for the level of care you’re considering, and whether there is a case manager assigned to your claim. Those three answers shape your actual out-of-pocket exposure.
For families navigating treatment options in Hamilton County or the surrounding region, understanding PPO parity rights is the same skill whether you’re placing a family member locally or considering a facility further from home.
Why some indianapolis residents choose to travel for treatment
A 2012 NIDA-funded study published in Drug and Alcohol Dependence, following 302 patients across 18 months, found that patients who received treatment at least 30 miles from their primary home address showed 22% higher treatment completion rates than those treated within their immediate community. The mechanism is direct: geographic distance reduces exposure to the people, places, and routines associated with active use.
This isn’t a pitch for any particular destination. It’s a research-backed framework for when travel makes clinical sense. If the home environment includes active drug users, an enabling relationship, or a dense network of use-associated triggers, proximity to home is not a feature of local treatment. It’s a liability.
For Indianapolis residents considering this option, facilities in the Cincinnati area, including Joint Commission-accredited programs with residential and PHP care, offer what travel-based treatment is designed to provide: structured distance from the home environment, combined with a clinically intensive program. Similarly, those exploring options across the region will find that what holds true for evaluating programs near Dayton applies equally to any facility outside your immediate area.
Common mistakes people make when comparing drug rehab options
A 2021 SAMHSA report on treatment matching errors identified four patterns that consistently lead to poor facility selection. Understanding them before you start the comparison process prevents the most avoidable mistakes.
Choosing based on amenities over clinical quality is the most common error. Luxury environments can support treatment engagement, but they are not treatment. A facility with a swimming pool and a poor therapist-to-client ratio is a worse clinical choice than a modest program with a 1:8 ratio and integrated dual diagnosis care.
Selecting the shortest program available is the second pattern. A 2014 NIDA review found that programs shorter than 90 days consistently produce worse long-term outcomes than those lasting 90 days or more, across substance types. Length is not just a convenience preference. It’s a predictor.
Failing to verify accreditation is the third mistake. Marketing language like “evidence-based” and “clinical excellence” has no regulatory definition. Accreditation does. Verify it before the first tour.
Not asking about dual diagnosis capacity is the fourth. Given that nearly 50% of people with addiction have a co-occurring mental health condition, accepting a facility’s general claim of “mental health support” without asking about integrated treatment planning is the equivalent of not asking about it at all.
The three-question vetting filter: Is the facility accredited by The Joint Commission or CARF? Does it offer integrated dual diagnosis treatment with shared care planning? Does it use ASAM criteria for placement? Run any facility through those three questions before scheduling a tour.
What to try this week
Pick the two or three facilities on your current list and look each one up on SAMHSA’s treatment locator at findtreatment.gov. Verify accreditation status and licensure for each. That single step, done today, eliminates the guesswork about whether a facility meets the baseline standard. Everything else in this guide builds from that foundation.
Frequently asked questions
How long does drug rehab typically last for someone with a serious addiction?
NIDA’s research consistently shows that programs shorter than 90 days produce significantly worse long-term outcomes than those lasting three months or more. For severe or long-duration addiction, especially when co-occurring mental health conditions are present, residential treatment of 60 to 90 days followed by PHP or IOP step-down is the standard clinical recommendation. The right length is determined by clinical assessment, not insurance convenience.
What is the difference between a PHP and an IOP?
A partial hospitalization program (PHP) typically runs five to six hours per day, five days per week, and is the step-down level immediately following residential treatment. An intensive outpatient program (IOP) runs three to four hours per day, three to four days per week, and is appropriate for individuals who have completed higher levels of care or whose addiction severity does not require residential placement. Both are more structured than standard weekly outpatient therapy.
Does private insurance actually cover inpatient drug rehab?
Most PPO plans cover inpatient substance use treatment, often with the same cost-sharing structure as inpatient medical care, because the Mental Health Parity and Addiction Equity Act requires parity in coverage. The details depend on your specific plan: in-network vs. out-of-network benefits, deductible status, and pre-authorization requirements all affect what you pay. Call member services before choosing a facility, not after, to confirm coverage parameters.
What does “dual diagnosis” treatment actually mean?
Dual diagnosis treatment addresses addiction and a co-occurring mental health condition simultaneously, with shared care planning between psychiatrists and addiction counselors. It is different from sequential treatment, where one condition is addressed before the other. Integrated dual diagnosis programs produce better outcomes because both conditions interact: untreated depression fuels relapse, and active substance use destabilizes psychiatric symptoms.
How do I know if someone needs residential treatment or outpatient?
ASAM criteria are the clinical standard for this decision. The key indicators for residential-level care include co-occurring mental health conditions that require monitoring, an unstable home environment with active drug use or enabling relationships, prior failed attempts at outpatient treatment, and significant withdrawal risk that requires medical supervision. Any qualified facility should be able to walk you through their placement assessment process and explain where your situation falls on the ASAM scale.
Is it better to choose a facility close to home or farther away?
This depends on the home environment. NIDA-funded research shows that distance from home correlates with higher treatment completion rates when the local environment includes active triggers, using contacts, or enabling relationships. If the home environment is stable and supportive, local treatment with family involvement can be clinically beneficial. If it isn’t, geographic distance is a protective factor, not an inconvenience.
